Michael Milos  Thornton net worth and biography

Michael Thornton Biography and Net Worth

Prior to joining ENDRA as chief technology officer in 2007, Michael Thornton was a founder and president of Enhanced Vision Systems Corp., or EVS, a developer and supplier of medical imaging equipment to the pharmaceutical, biotech and academic sectors.

In 2002, EVS was acquired by General Electric Company. Following the acquisition of EVS by GE, Thornton held a number of positions at GE Healthcare, including sales manager, global product manager and site leader. He was a member of the leadership team that expanded the pre-clinical imaging business to include: computed tomography, optical and positron emission tomography imaging technologies, with global market reach. He is also a founder of Volumetrics Medical Corp., a developer and manufacturer of quality assurance devices for diagnostic imaging.

Prior to founding EVS, Thornton developed medical imaging related technologies at the Robarts Research Institute (London, Ontario, Canada) for which he obtained a master’s in electrical engineering from the University of Western Ontario. Thornton also holds a bachelor’s in electrical engineering from the University of Toronto and is a member of the American Association of Physicists in Medicine.

What is Michael Milos Thornton's net worth?

The estimated net worth of Michael Milos Thornton is at least $8,541.58 as of May 18th, 2023. Mr. Thornton owns 34,139 shares of ENDRA Life Sciences stock worth more than $8,542 as of April 23rd. This net worth estimate does not reflect any other assets that Mr. Thornton may own. Additionally, Mr. Thornton receives a salary of $301,670.00 as CTO at ENDRA Life Sciences. Learn More about Michael Milos Thornton's net worth.

How old is Michael Milos Thornton?

Mr. Thornton is currently 56 years old. There are 2 older executives and no younger executives at ENDRA Life Sciences. The oldest executive at ENDRA Life Sciences is Mr. Francois Michelon, Chairman, President & CEO, who is 58 years old. Learn More on Michael Milos Thornton's age.

What is Michael Milos Thornton's salary?

As the CTO of ENDRA Life Sciences Inc., Mr. Thornton earns $301,670.00 per year. The highest earning executive at ENDRA Life Sciences is Mr. Francois Michelon, Chairman, President & CEO, who commands a salary of $423,590.00 per year. Learn More on Michael Milos Thornton's salary.

How do I contact Michael Milos Thornton?

The corporate mailing address for Mr. Thornton and other ENDRA Life Sciences executives is 3600 GREEN COURT SUITE 350, ANN ARBOR MI, 48105. ENDRA Life Sciences can also be reached via phone at (734) 335-0468 and via email at [email protected]. Learn More on Michael Milos Thornton's contact information.

Has Michael Milos Thornton been buying or selling shares of ENDRA Life Sciences?

Michael Milos Thornton has not been actively trading shares of ENDRA Life Sciences during the last ninety days. Most recently, on Thursday, May 18th, Michael Milos Thornton bought 15,000 shares of ENDRA Life Sciences stock. The stock was acquired at an average cost of $1.65 per share, with a total value of $24,750.00. Following the completion of the transaction, the chief technology officer now directly owns 34,139 shares of the company's stock, valued at $56,329.35. Learn More on Michael Milos Thornton's trading history.

Who are ENDRA Life Sciences' active insiders?

ENDRA Life Sciences' insider roster includes Lou Basenese (Director), and Michael Thornton (CTO). Learn More on ENDRA Life Sciences' active insiders.

Are insiders buying or selling shares of ENDRA Life Sciences?

In the last year, ENDRA Life Sciences insiders bought shares 2 times. They purchased a total of 98,333 shares worth more than $124,749.60. The most recent insider tranaction occured on May, 18th when CTO Michael Milos Thornton bought 15,000 shares worth more than $24,750.00. Insiders at ENDRA Life Sciences own 4.8% of the company. Learn More about insider trades at ENDRA Life Sciences.

Information on this page was last updated on 5/18/2023.

Michael Milos Thornton Insider Trading History at ENDRA Life Sciences

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
5/18/2023Buy15,000$1.65$24,750.0034,139View SEC Filing Icon  
12/9/2022Buy1,500$3.40$5,100.0019,139View SEC Filing Icon  
8/22/2022Buy20,000$0.27$5,400.00352,775View SEC Filing Icon  
5/26/2022Buy25,000$0.21$5,250.00332,775View SEC Filing Icon  
5/18/2022Buy25,000$0.22$5,500.00307,775View SEC Filing Icon  
4/7/2021Sell15,000$2.53$37,950.00274,960View SEC Filing Icon  
3/29/2021Sell18,750$2.37$44,437.50274,960View SEC Filing Icon  
5/16/2019Buy30,000$1.13$33,900.00View SEC Filing Icon  
See Full Table

Michael Milos Thornton Buying and Selling Activity at ENDRA Life Sciences

This chart shows Michael Milos Thornton's buying and selling at ENDRA Life Sciences by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

ENDRA Life Sciences Company Overview

ENDRA Life Sciences logo
ENDRA Life Sciences Inc. develops technology for improving the capabilities of clinical diagnostic ultrasound. The company develops thermo-acoustic enhanced ultrasound technology that transmits sound waves, which bounce off tissues, organs, and blood in the body for use in the treatment of nonalcoholic fatty liver disease, as well as in tissue composition, temperature monitoring, vascular imaging, and tissue perfusion. It also offers diagnostic imaging technologies, such as computed tomography, magnetic resonance imaging, and ultrasound that allow physicians to look inside a person's body to guide treatment or gather information about medical conditions, such as broken bones, cancers, signs of heart disease, or internal bleeding. The company has a collaborative research agreement with General Electric Company. ENDRA Life Sciences Inc. was incorporated in 2007 and is based in Ann Arbor, Michigan.
Read More

Today's Range

Now: $0.25
Low: $0.25
High: $0.25

50 Day Range

MA: $0.82
Low: $0.23
High: $1.21

2 Week Range

Now: $0.25
Low: $0.22
High: $2.79

Volume

18,144 shs

Average Volume

277,993 shs

Market Capitalization

$2.76 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.98